Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4951]

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive...

New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumour

New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumour

IAEA strengthens cooperation in cancer care at Europe and Central Asia’s first anchor centre in Türkiye

IAEA strengthens cooperation in cancer care at Europe and Central Asia’s first anchor centre in Türkiye

Researchers identify biomarkers in blood to predict liver cancer

Researchers identify biomarkers in blood to predict liver cancer

Promising personalised approach to liver cancer therapy made possible by DNA-based neoantigen research

Promising personalised approach to liver cancer therapy made possible by DNA-based neoantigen research

FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer

FDA approves tisotumab vedotin-tftv for recurrent or metastatic cervical cancer

A closed-loop drug-delivery system could improve chemotherapy

A closed-loop drug-delivery system could improve chemotherapy

New study points to racial and social barriers that block treatment for multiple myeloma

New study points to racial and social barriers that block treatment for multiple myeloma

Many people with breast cancer ‘systematically left behind’ due to inaction on inequities and hidden suffering

Many people with breast cancer ‘systematically left behind’ due to inaction on inequities and hidden suffering

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

More from ecancer